Evidence map›Paper›PMID 30134632›Full record

ArticleJournal of clinical medicine2018

Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation.

Ya-Hui Wang, Chih-Cheng Lai, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu, Likwang Chen, Taiwan Clinical Trial Consortium for Respiratory Diseases

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ya-Hui WangMedical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City 23141, Taiwan. yhwang531@gmail.com.
Chih-Cheng LaiDepartment of Intensive Care Medicine, Chi Mei Medical Center, Liouying 73657, Taiwan. dtmed141@gmail.com.
Cheng-Yi WangDepartment of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu-Jen Catholic University, No.362, Zhongzheng Road, Xindian District, New Taipei City 23148, Taiwan. cywang@mospital.com.
Hao-Chien WangDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei 10048, Taiwan. haochienwang@gmail.com.
Chong-Jen YuDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei 10048, Taiwan. jefferycjyu@ntu.edu.tw.ORCID 0000-0001-5664-9392
Likwang ChenInstitute of Population Health Sciences, National Health Research Institutes, Zhunan 35053, Taiwan. likwang.chen@gmail.com.
Taiwan Clinical Trial Consortium for Respiratory Diseases
Fu Jen Catholic University · TWNational Taiwan University Hospital · TWChi Mei Medical Center · TWNational Health Research Institutes · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between Atrial Fibrillation (AF) and pneumonia remains unclear. This study aims to assess the impact of AF on high pneumonia risk group-chronic obstructive pulmonary disease (COPD)-In order to find the association between AF and the risk of pneumonia. The COPD cohort was extracted from National Health Research Institute of Taiwan. The AF cohort comprised all COPD patients with new-onset AF (International Classification of Diseases (ICD)-9 code 427.31) after COPD diagnosis. We further sampled non-AF cohort and performed 1:1 propensity score matched analysis to improve the balance of baseline characteristics between AF and non-AF cohort. The outcomes were pneumonia and pneumonia requiring mechanical ventilation (MV). From 2000⁻2011, a total of 6228 patients with COPD and AF, and matched 84,106 control subjects were enrolled. After propensity score matching, we identified 6219 patients, each with AF, and matched controls without AF. After propensity score matching, the AF cohorts had higher risk of mortality (adjusted hazard ratio (aHR), 1.24; 95% confidence interval (CI), 1.15⁻1.34), pneumonia (aHR, 1.17; 95% CI, 1.07⁻1.27), and pneumonia requiring MV (aHR, 1.33; 95% CI, 1.18⁻1.50) in comparison with the matched non-AF cohort. After adjusting for mortality from causes other than outcomes of interest as a competing risk, AF remains significantly associated with pneumonia and pneumonia requiring MV. The risks of pneumonia were higher in this population with AF than in those without AF, and the risk was still significant after the adjustment for the competing risk of all-cause mortality.

Indexed as

atrial fibrillationchronic obstructive pulmonary diseasepneumoniarisk

Identifiers

PMID30134632
PMCPMC6162855
OpenAlexW2888423733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.